American Journal of Clinical Dermatology

, Volume 14, Issue 1, pp 1–7

Risk of Cardiovascular Disorders in Psoriasis Patients

Current and Future

Authors

  • Ingrid L. D. Tablazon
    • Department of Dermatology, Center for Dermatology ResearchWake Forest School of Medicine
  • Amir Al-Dabagh
    • Department of Dermatology, Center for Dermatology ResearchWake Forest School of Medicine
    • Department of Dermatology, Center for Dermatology ResearchWake Forest School of Medicine
  • Steven R. Feldman
    • Department of Dermatology, Center for Dermatology ResearchWake Forest School of Medicine
    • Department of Pathology, Center for Dermatology ResearchWake Forest School of Medicine
    • Department of Public Health Sciences, Center for Dermatology ResearchWake Forest School of Medicine
Leading Article

DOI: 10.1007/s40257-012-0005-5

Cite this article as:
Tablazon, I.L.D., Al-Dabagh, A., Davis, S.A. et al. Am J Clin Dermatol (2013) 14: 1. doi:10.1007/s40257-012-0005-5

Abstract

Psoriasis is an inflammatory autoimmune disease that affects the skin. Recently, psoriasis and its consequential lifestyle and dietary habits have been associated with increased risks for cardiovascular diseases. This article discusses the connection between cardiovascular disorders and psoriasis and the effects of available treatment options on cardiovascular risk. A PubMed search revealed 11 articles that were analyzed for information regarding this association, its effects, and potential courses of treatment. Both the presence and severity of psoriasis increases the risk for cardiovascular disorders and co-morbidities. Forty percent of psoriasis patients met metabolic syndrome criteria as compared with 23 % of non-psoriasis control subjects. Rate ratios for atrial fibrillation are correlated with the severity of psoriasis; patients with severe and mild psoriasis produced rate ratios of 1.63 and 1.31, respectively. Studies also show an increase in the risks for myocardial infarction, atherosclerosis, ischemic stroke, and other cardiovascular disorders. The exact mechanisms behind this affiliation are still uncertain; however, the psychological and physiological effects of psoriasis and the overlapping pathogenesis behind atherosclerosis and psoriasis may play a role. Since the risk for cardiovascular disorders increases with the presence and severity of psoriasis, psoriasis treatment should not only address the disease and its symptoms, but also its co-morbidities. Recent National Psoriasis Foundation (NPF) guidelines have provided recommendations for psoriasis patient care. Histories of co-morbidities, screenings for potential diseases, increased exercise, decreased alcohol consumption, and smoking cessation should be implemented. Unfortunately, while there are data for the increased risk for cardiovascular diseases within psoriasis patients, there are presently no data stating that increasing cardiovascular screening rates in patients produces a significant difference.

Copyright information

© Springer International Publishing Switzerland 2012